Competitive inhibition of drug-protein interaction in eye fluids and tissues.
D000818:Animals; D001667:Binding, Competitive; D001702:Biopharmaceutics; D002594:Cetylpyridinium / Q000494:pharmacology; D003315:Cornea / Q000187:drug effects; D003956:Dialysis; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D005029:Ethylenediamines / Q000378:metabolism; D005123:Eye / Q000378:metabolism*; D005136:Eye Proteins / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D008775:Methylprednisolone / Q000378:metabolism; D008916:Miotics / Q000494:pharmacology; D009281:Naphthalenes / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010862:Pilocarpine / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D011817:Rabbits; D012709:Serum Albumin / Q000378:metabolism; D013444:Sulfisoxazole / Q000378:metabolism; D013501:Surface-Active Agents / Q000494:pharmacology; D013997:Time Factors
D005029:Ethylenediamines; D005136:Eye Proteins; D008916:Miotics; D009281:Naphthalenes; D004364:Pharmaceutical Preparations; D012709:Serum Albumin; D013501:Surface-Active Agents; D010862:Pilocarpine; D013444:Sulfisoxazole; D002594:Cetylpyridinium; D008775:Methylprednisolone